TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank100
3Y CAGR+1.3%
5Y CAGR+55.2%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
+1.3%/yr
Annual compound
5Y CAGR
+55.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
20251.04+20.0%
20240.87+26.4%
20230.69-31.5%
20221.00+0.3%
20211.00+765.2%
20200.12-87.4%
20190.92-